Literature DB >> 33879210

Research on clinical characteristics and prognostic analysis of heparin-induced thrombocytopenia after surgery for acute type a aortic dissection.

Chu-Zhi Zhou1,2, Dong-Jie Feng2, Yan-Zhen Li1, Yuan Fang2, Feng-Yan Zha2, Er-Hui Wang2, Min-Xin Wei3, Jun-Min Wen4.   

Abstract

PURPOSE: The present study aimed to explore the clinical characteristics of heparin-induced thrombocytopenia (HIT) after surgery for acute type A aortic dissection and perform a relevant prognostic analysis.
METHODS: After continuous observation and analysis of 204 patients who underwent acute type A aortic dissection, we found that blood platelets decreased significantly after surgery and that these patients can be suspected to suffer HIT based on relevant 4Ts scores. For these suspected HIT patients, a latex particle-enhanced immunoturbidimetric assay was conducted to detect heparin-induced antibodies. Perioperative clinical data of patients in HIT and non-HIT groups were recorded as were blood platelet counts, HIT antibody test results, 4Ts scores, thromboembolic complications, clinical prognosis and outcomes.
RESULTS: In the present study, 38 suspected HIT patients, 16 HIT patients and 188 non-HIT patients were selected in the clinical setting. Among them, HIT patients were found to have prolonged cardiopulmonary bypass time (223 min on average vs. 164 min) and delayed aortic cross-clamp time (128 min on average vs. 107 min), and these differences between HIT patients and non-HIT patients were significant (P < 0.05). Additionally, the HIT group required longer operation time and higher dose of heparin, but showing no statistical differences (P > 0.05). The transfusions of blood platelets in the HIT group and non-HIT group were 18.7 ± 5.0u and 15.6 ± 7.34 u, respectively. In the HIT group, the mechanic ventilation time and the length of ICU stay were longer comparing the non-HIT group(P < 0.05), though no significant differences in total length of stay or In-hospital mortality were observed (P > 0.05). The incidence of continuous renal replacement therapy in HIT group was higher than the non-HIT group (P < 0.05). Additionally,there were no significant differences in 24-h postoperative drainage or reoperation for bleeding in both group(P > 0.05). However, the HIT antibody titer in the HIT group was significantly higher than that in the Suspected HIT group (2.7 ± 0.8 U/mL vs. 0.3 ± 0.2 U/mL) (P < 0.05). Among patients diagnosed with HIT, the incidence of thromboembolism reached 31.5%.For example, two HIT patients newly developed thromboembolism in both lower extremities,and three patients experienced cerebral infarction.
CONCLUSIONS: After surgery for acute type A aortic dissection, HIT patients developed postoperative complications, the duration of ventilatory support and length of ICU stay were extended, and the incidence of thromboembolism increased. HIT antibody detection and risk classification should be implemented for high-risk patients showing early clinical characteristics.

Entities:  

Keywords:  Acute type a aortic dissection (ATAAD);blood platelet count;cardiopulmonary bypass (CPB);heparin-induced thrombocytopenia;heparin;thrombosis

Year:  2021        PMID: 33879210     DOI: 10.1186/s13019-021-01482-2

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  20 in total

1.  Platelet Counts and Postoperative Stroke After Coronary Artery Bypass Grafting Surgery.

Authors:  Jörn A Karhausen; Alan M Smeltz; Igor Akushevich; Mary Cooter; Mihai V Podgoreanu; Mark Stafford-Smith; Susan M Martinelli; Manuel L Fontes; Miklos D Kertai
Journal:  Anesth Analg       Date:  2017-10       Impact factor: 5.108

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

Authors:  Bruno Girolami; Paolo Prandoni; Piero M Stefani; Cinzia Tanduo; Paola Sabbion; Petra Eichler; Roberto Ramon; Giovannella Baggio; Fabrizio Fabris; Antonio Girolami
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

4.  Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.

Authors:  Henry Watson; Simon Davidson; David Keeling
Journal:  Br J Haematol       Date:  2012-10-09       Impact factor: 6.998

5.  Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.

Authors:  Anand Padmanabhan; Curtis G Jones; Daniel W Bougie; Brian R Curtis; Janice G McFarland; Demin Wang; Richard H Aster
Journal:  Blood       Date:  2014-10-23       Impact factor: 22.113

Review 6.  Profile of Instrumentation Laboratory's HemosIL® AcuStar HIT-Ab(PF4-H) assay for diagnosis of heparin-induced thrombocytopenia.

Authors:  Michael Nagler; Adam Cuker
Journal:  Expert Rev Mol Diagn       Date:  2017-03-16       Impact factor: 5.225

Review 7.  Heparin-Induced Thrombocytopenia: A Comprehensive Clinical Review.

Authors:  Benjamin S Salter; Menachem M Weiner; Muoi A Trinh; Joshua Heller; Adam S Evans; David H Adams; Gregory W Fischer
Journal:  J Am Coll Cardiol       Date:  2016-05-31       Impact factor: 24.094

Review 8.  Immune pathogenesis of heparin-induced thrombocytopenia.

Authors:  Sanjay Khandelwal; Gowthami M Arepally
Journal:  Thromb Haemost       Date:  2016-07-28       Impact factor: 5.249

9.  Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.

Authors:  Robert A Raschke; Steven C Curry; Theodore E Warkentin; Richard D Gerkin
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  An Anti-Coagulation Conundrum: Implantation of Total Artificial Heart in a Patient with Heparin-Induced Thrombocytopenia Type II.

Authors:  Theodore J Cios; Yuliana Salamanca-Padilla; Dmitri Guvakov
Journal:  Am J Case Rep       Date:  2017-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.